Health Insurance Recovery: Claims Ratio Hits Five-Year Low as Industry Stabilizes Post-Pandemic

Published: February 12, 2026

NEW DELHI — India’s health insurance sector has reached a pivotal financial turning point, marking its strongest performance since the onset of the global pandemic. According to the latest data from the Insurance Regulatory and Development Authority of India (IRDAI), the industry-wide Incurred Claims Ratio (ICR) dropped to a post-COVID low of 86.9% for the 2024-25 fiscal year (FY25). This shift, down from a staggering peak of 109% in 2022, suggests that insurers have finally balanced the scales between rising medical costs and premium collections, offering a more stable outlook for the 580 million lives now covered under health policies.

Understanding the Shift: From Deficit to Discipline

The Incurred Claims Ratio is a critical health metric for the insurance industry. It measures the percentage of premiums used to pay out claims. In simple terms: for every ₹100 collected in premiums during FY25, insurers paid out ₹86.90 in claims, leaving a margin of ₹13.10 to cover operational costs and reserve capital.

This is a stark contrast to the FY22 period, where the ICR hit 109.12%. During that time, insurers were paying out more than they were bringing in—a direct result of the surge in hospitalizations during the Delta wave of COVID-19.

“The recovery we are seeing is the result of necessary, albeit difficult, price corrections and a more disciplined approach to underwriting,” says a senior industry analyst. “While the pandemic was a stress test that nearly broke the system, it has led to a more resilient framework today.”

Key Data Points from the FY25 IRDAI Report:

• Total Premiums: The sector grew to ₹1.17 trillion, a 9.12% increase year-on-year.

• Net Claims: Total payouts reached ₹84,850 crore, up 11% from the previous year.

• Settlement Volume: 3.26 crore claims were settled, with 66% processed through cashless facilities.

• Coverage Growth: The number of insured individuals rose to 580 million, up from 573 million in FY24.

The Divergent Tale of Insurers

While the industry average looks healthy, a closer look reveals a significant divide between different types of providers.

Standalone Health Insurers (SAHIs), such as Care Health and Niva Bupa, emerged as the most efficient, reporting a combined ICR of 68.06%. Experts attribute this to their specialized focus on individual retail policies and more rigorous risk management.

Conversely, Public Sector Undertakings (PSUs) continue to struggle, particularly in the “Group Health” segment (insurance provided by employers). PSUs reported an ICR of 103.61% in this category. Because large corporations often use their bargaining power to keep premiums low, public insurers frequently end up paying out more in claims than they collect, leading to underwriting losses of roughly ₹925 crore this past year.

The “Medical Inflation” Reality Check

Despite the improved financial health of insurers, policyholders face a daunting challenge: medical inflation. In India, the cost of healthcare is rising at an annual rate of 12% to 15%—nearly double the rate of general inflation.

“Post-COVID price corrections have been crucial in stabilizing the sector, but sustained medical inflation demands ongoing vigilance,” noted IRDAI Chairman Ajay Seth in a recent industry address. He emphasized that while insurers are now on firmer ground, they must prioritize “prompt and fair settlements” to maintain public trust.

For the average consumer, this inflation means that a ₹5 lakh policy purchased three years ago may no longer be sufficient to cover a major surgery today.

Challenges: Grievances and Settlement Gaps

It isn’t all good news. While the industry is more profitable, consumer dissatisfaction is on the rise. Reported grievances spiked by 41%, reaching 1.37 lakh complaints in FY25. Many of these stem from delays in claim processing and “partial settlements,” where insurers use fine-print clauses to avoid paying the full hospital bill.

Furthermore, while the volume of claims grew by 21%, the rate of settlements grew at a slower pace of 12.8%. This gap suggests that the administrative machinery of insurance companies is struggling to keep up with the sheer volume of paperwork and verification required.

What This Means for Your Family’s Health Plan

The stabilization of the ICR is generally good for consumers because it prevents “panic hikes” in premiums. However, the high medical inflation rate means you cannot afford to be passive about your coverage.

Actionable Advice for Policyholders:

1. Review the Sum Insured: Experts recommend increasing your coverage by 10-15% annually to keep pace with the rising costs of private hospital rooms and advanced procedures.

2. Check the Claim Settlement Ratio (CSR): Do not look at the ICR alone. Look for insurers with a CSR above 85%, which indicates a higher likelihood that your claim will be approved.

3. The “Retail” Advantage: If you rely solely on company-provided (Group) insurance, consider a “Top-up” or a standalone retail policy. As PSUs face losses in group insurance, premiums for those plans are expected to rise sharply.

4. Embrace Cashless: With 66% of claims now cashless, choosing an insurer with a robust network of hospitals near you can significantly reduce your out-of-pocket burden during an emergency.

The Road Ahead

As India aims to increase insurance penetration from its current 3.7% of GDP toward the global average of 7%, the financial recovery of insurers provides a necessary foundation. A profitable industry is one that can afford to innovate, offer new products for chronic disease management, and expand into rural areas.

However, the friction between rising premiums and increasing consumer grievances remains a hurdle. The coming year will likely see the IRDAI tighten regulations around Third-Party Administrators (TPAs) and settlement timelines to ensure that the industry’s financial “bounce back” translates into better care for the policyholders.

Medical Disclaimer

This article is for informational purposes only and should not be considered medical advice. Always consult with qualified healthcare professionals before making any health-related decisions or changes to your treatment plan. The information presented here is based on current research and expert opinions, which may evolve as new evidence emerges.

References

https://health.economictimes.indiatimes.com/news/insurance/health-insurers-get-back-in-shape-post-covid-low/128208692?utm_source=top_story&utm_medium=homepage